Skip to content

The study to evaluate the efficacy and safety of using Platelet-rich plasma combined with hyaluronic acid for treating neck rejuvenation in Thailand.

The study to evaluate the efficacy and safety of using Platelet-rich plasma combined with hyaluronic acid for treating neck rejuvenation in Thailand.

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230212003
Enrollment
32
Registered
2023-02-12
Start date
2023-02-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Platelet-rich plasma, neck rejuvenation, hyaluronic acid

Interventions

Patients were treated with Platelet-rich plasma combined with hyaluronic acid at neck for 3 sessions every 4 weeks. Then they were instructed to follow up at 2 weeks, 1 month, 2 months, 3 months, 6 m
Experimental Device

Sponsors

ASTRACO MEDICAL NETWORKS LTD.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 30-60 years old 2. Both male and female 3. Neck laxity grade 1-5 from Wrinkle Assessment Scale of horizontal neck folds

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnant 2. Subjects who had history of low platelet, coagulopathy or taking medicine of antocoagulant drug like warfarin 3. Subjects who has dermatits, wound or infection at treatment area 4. Subjects who allergy to anesthesia cream 5. Subjects who taken oral or injection contraceptive pills 6. Subjects who had history of laser at treatment area within 6 months before arrived the project 7. Subjects who had history of keloid or hypertrophic scar 8. Subjects who had history of psychitic disease

Design outcomes

Primary

MeasureTime frame
Average Wrinkle and Texture Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments Antera

Secondary

MeasureTime frame
Volume change Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments Vectra,Melanin index Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments mexameter,Erythema Index Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments Mexameter,Skin elasticity Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments Cutometer,Skin hydration Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments Corneometer,Skin lightness Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments Colorimeter,Sebum index Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments sebumeter,Physician improvement scale Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments Percent improvement,Patient improvement scale Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments percent improvement,safety Baseline,1 month after 1st treatment, 1 months after 2nd treatment and 2 week, 1,2,3,6 months after 3rd treatments adverse effect

Countries

Thailand

Contacts

Public ContactRungsima Wanitphakdeedecha

Faculty of Medicine Siriraj Hospital, Mahidol University

rungsima.wan@mahidol.ac.th66816406300

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026